Publications by authors named "Shiwei Deng"

Claim this Profile
M
Modeling on disposition and cellular transportation of RNA lipid nanoparticles quantum mechanics/physiologically-based pharmacokinetic approaches.
Wei Wang, Shiwei Deng, Jinzhong Lin, Defang Ouyang

Acta Pharm Sin B· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistically Engineering Grains and Grain Boundaries toward Li Dendrite-Free LiLaZrO.
Shiwei Deng, Huilin Zhu, Zhiyuan Zheng, Zixiang Kong, Zixing Wang

Nano Lett· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma.
Annegret Reichwagen, Marita Ziepert, Markus Kreuz, Ute Gödtel-Armbrust, Tanja Rixecker, Shiwei Deng

Pharmacogenomics· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
Shiwei Deng, Tiandong Yan, Teodora Nikolova, Dominik Fuhrmann, Andrea Nemecek

Br J Pharmacol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidants and antioxidants in metabolic syndrome and cancer.
Si Jin, Yongzhong Wu, Shiwei Deng, Jinxiang Zhang, Xiao Qian Chen

Oxid Med Cell Longev· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
Shiwei Deng, Tiandong Yan, Cathleen Jendrny, Andrea Nemecek, Mladen Vincetic

BMC Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary history and functional characterization of the amphibian xenosensor CAR.
Marianne Mathäs, Oliver Burk, Huan Qiu, Christian Nusshag, Ute Gödtel-Armbrust, Shiwei Deng

Mol Endocrinol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice.
Shiwei Deng, Anke Kruger, Albrecht Schmidt, Annegret Metzger, Tiandong Yan

Naunyn Schmiedebergs Arch Pharmacol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase II{alpha}-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin.
Tiandong Yan, Shiwei Deng, Annegret Metzger, Ute Gödtel-Armbrust, Andrew C G Porter

Mol Cancer Ther· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studies.
Marit Holden, Shiwei Deng, Leszek Wojnowski, Bettina Kulle

Bioinformatics· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotyping the risk of anthracycline-induced cardiotoxicity.
Shiwei Deng, Leszek Wojnowski

Cardiovasc Toxicol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity.
Shiwei Deng, Bettina Kulle, Mehdi Hosseini, Gregor Schlüter, Gerd Hasenfuss

Eur J Heart Fail· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH.
Shiwei Deng, Anke Kruger, Andrei L Kleschyov, Leszek Kalinowski, Andreas Daiber

Free Radic Biol Med· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis